Top Stories
-
Compassionate use of an antisense drug first used at Columbia to treat an aggressive type of ALS caused by mutations in the FUS gene markedly reduces toxic proteins in the nervous system.
Topic
-
A new study at Columbia University Irving Medical Center seeks volunteers to determine if intermittent fasting leads to long-term weight loss and health benefits.
Topic
-
Catch up on some of the scientific discoveries made by CUIMC researchers in 2021.
-
CDM alumnus Lawrence A. Tabak, DDS, PhD, today took on the role of acting director of the National Institutes of Health, succeeding Francis Collins.
Topic
Latest News
- January 4, 2021
New images of Wnt, a signaling protein mutated in some cancers, in complex with its specific carrier, reveals atomic-level details of the molecules and a potential new drug target.
- December 23, 2020
A new study conducted at Columbia and other centers found that 80% of patients with a type of slow-growing lymphoma achieved a complete remission with a single infusion of CAR T-cell immunotherapy.
Topic
- December 22, 2020
In children with certain autism mutations, the diversity and severity of symptoms are often related to the identity and properties of gene units, called exons, targeted by the mutations.
Topic
- December 18, 2020
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
Topic
- December 4, 2020
Columbia researchers created a new technology using synthetic llama antibodies to protect endangered proteins inside cells. The technology could treat dozens of diseases.
- December 2, 2020
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
Topic
- December 1, 2020
New findings suggest a hormone called lipocalin-2, previously found to suppress food intake in mice, may also prevent weight gain in humans.
Topic
- November 27, 2020
Columbia researchers characterized a new class of ‘biomimetic’ drugs that plug a calcium channel implicated in the development of cancer and several other diseases.
Topic
- November 19, 2020
Columbia University COVID researchers are working to improve coronavirus testing, find new antivirals, and develop new ways to prevent transmission.
Topic
- November 16, 2020
A new nationwide study of more than 50,000 individuals—coordinated by Columbia researchers—is now underway to determine factors that predict disease severity and long-term health impacts of COVID-19.
Topic
